. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Pediatr Blood Cancer. 2013 Nov 1;61(4):601–605. doi: 10.1002/pbc.24830

Table II.

Patient Characteristics

Characteristic		n (%) (n = 379)
Gender	Male	243 (64%)
Gender	Female	136 (36%)
Race	White	293 (77%)
Race	Non-white	86 (23%)
Age at diagnosis (years)	Median	8.2
	Range	3.0–21.6
	Interquartile Range	6.2 – 10.9
Age at latest audiogram (years)	Median	9.7
	Range	3.7 – 22.5
	Interquartile Range	7.6 – 12.4
Time from treatment initiation to latest audiogram (months)	Median	19.1
	Range	5.6 – 24.5
	Interquartile Range	12.4 – 22.6
Disease Risk	Average	263 (69%)
Disease Risk	High	116 (31%)
Study	SJMB03	266 (70%)
Study	SJMB96	113 (30%)
Institution	St. Jude	192 (51%)
Institution	Collaborative site	187 (49%)
Amifostine	No	51(13%)
Amifostine	Yes	328 (87%)
Cisplatin cumulative dose (mg/m2)	Median	300
	Range	74 – 329
	Interquartile Range	295 – 302